Bellevue Group’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$132M Sell
286,654
-35,374
-11% -$17.9M 3.14% 8
2025
Q4
$182M Sell
322,028
-26,598
-8% -$14.2M 3.46% 7
2025
Q3
$156M Sell
348,626
-30,102
-8% -$14.4M 3.24% 10
2025
Q2
$206M Sell
378,728
-47,018
-11% -$24.6M 4.54% 7
2025
Q1
$211M Sell
425,746
-38,631
-8% -$21.4M 4.72% 4
2024
Q4
$242M Sell
464,377
-32,398
-7% -$16.9M 4.67% 4
2024
Q3
$244M Sell
496,775
-43,129
-8% -$20.1M 3.95% 4
2024
Q2
$240M Sell
539,904
-142,282
-21% -$56.7M 3.9% 5
2024
Q1
$272M Sell
682,186
-149,855
-18% -$56.6M 4.15% 5
2023
Q4
$281M Buy
832,041
+3,042
+0.4% +$907K 4.29% 5
2023
Q3
$242M Sell
828,999
-13,225
-2% -$4.13M 3.9% 5
2023
Q2
$288M Sell
842,224
-126,562
-13% -$38.3M 4.11% 4
2023
Q1
$247M Buy
968,786
+11,700
+1% +$2.88M 3.59% 5
2022
Q4
$254M Buy
957,086
+58,994
+7% +$14.4M 3.37% 6
2022
Q3
$168M Sell
898,092
-11,256
-1% -$2.42M 2.42% 8
2022
Q2
$183M Buy
909,348
+289,280
+47% +$67.9M 2.58% 8
2022
Q1
$187M Buy
620,068
+35,605
+6% +$10.4M 2.17% 11
2021
Q4
$210M Sell
584,463
-26,322
-4% -$9.06M 2.16% 11
2021
Q3
$202M Buy
610,785
+4,500
+0.7% +$1.51M 2.05% 8
2021
Q2
$186M Sell
606,285
-56,040
-8% -$15.7M 1.81% 11
2021
Q1
$163M Buy
662,325
+74,265
+13% +$18.7M 1.73% 13
2020
Q4
$160M Buy
588,060
+128,508
+28% +$31.9M 1.84% 13
2020
Q3
$109M Sell
459,552
-9,147
-2% -$2.05M 1.5% 15
2020
Q2
$89M Sell
468,699
-192,414
-29% -$34.5M 1.26% 22
2020
Q1
$109M Buy
661,113
+132,285
+25% +$24.2M 2.12% 12
2019
Q4
$104M Buy
528,828
+1,893
+0.4% +$354K 1.65% 14
2019
Q3
$94.8M Buy
526,935
+21,489
+4% +$3.72M 1.76% 14
2019
Q2
$88.4M Buy
505,446
+52,449
+12% +$8.99M 1.51% 17
2019
Q1
$86.2M Buy
452,997
+36,606
+9% +$6.51M 4.74% 2
2018
Q4
$66.5M Buy
416,391
+152,787
+58% +$25.9M 4.37% 4
2018
Q3
$50.4M Buy
263,604
+387
+0.1% +$68.7K 3.2% 7
2018
Q2
$42M Buy
263,217
+15,447
+6% +$2.36M 3.58% 4
2018
Q1
$34.1M Sell
247,770
-40,623
-14% -$5.67M 3.38% 4
2017
Q4
$35.1M Buy
288,393
+15,000
+5% +$1.88M 3.67% 4
2017
Q3
$31.8M Buy
273,393
+60,039
+28% +$6.54M 3.32% 7
2017
Q2
$22.2M Buy
213,354
+16,029
+8% +$1.54M 2.62% 7
2017
Q1
$16.8M Buy
197,325
+116,325
+144% +$9.19M 2.24% 11
2016
Q4
$5.71M Sell
81,000
-27,000
-25% -$1.99M 1.17% 29
2016
Q3
$8.7M Hold
108,000
1.57% 22
2016
Q2
$7.94M Sell
108,000
-9,000
-8% -$633K 1.49% 22
2016
Q1
$7.81M Buy
+117,000
New +$7.25M 1.42% 21

Other funds holding ISRG

Bellevue Group's ISRG Position: Q1 2026 in Review

Bellevue Group reduced its Intuitive Surgical (ISRG) stake by 11% in Q1 2026, selling an estimated $17.9M and leaving 286,654 shares worth $132M. The position accounts for 3.14% of the portfolio, ranked #8.

Bellevue Group first reported a position in ISRG in Q1 2016 and has held it in 41 quarters since. The position peaked at $288M in Q2 2023. 2,302 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Bellevue Group held 286,654 shares of Intuitive Surgical worth $132M as of Q1 2026.
  • Bellevue Group sold 35,374 Intuitive Surgical shares in Q1 2026, an estimated $17.9M.
  • Intuitive Surgical made up 3.14% of Bellevue Group's portfolio in Q1 2026, its #8 holding.
  • Bellevue Group first reported a position in Intuitive Surgical in Q1 2016 and has held it in 41 quarters since.
  • Bellevue Group's Intuitive Surgical position peaked at $288M in Q2 2023.
  • 2,302 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Bellevue Group's 13F filing for Q1 2026, filed 15 May 2026.